denkapparat Operations GmbH Acquires New Position in Chemed Corporation $CHE

denkapparat Operations GmbH acquired a new stake in Chemed Corporation (NYSE:CHE) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 1,370 shares of the company’s stock, valued at approximately $638,000.

Other institutional investors have also bought and sold shares of the company. Monetary Solutions Ltd acquired a new stake in shares of Chemed in the fourth quarter valued at approximately $25,000. Los Angeles Capital Management LLC acquired a new position in Chemed during the fourth quarter worth $26,000. BOK Financial Private Wealth Inc. purchased a new stake in Chemed in the 4th quarter valued at $27,000. Mitsubishi UFJ Asset Management Co. Ltd. purchased a new stake in Chemed in the 2nd quarter valued at $34,000. Finally, Versant Capital Management Inc increased its stake in shares of Chemed by 7,500.0% in the 2nd quarter. Versant Capital Management Inc now owns 76 shares of the company’s stock worth $35,000 after acquiring an additional 75 shares during the last quarter. 95.85% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Weiss Ratings upgraded Chemed from a “hold (c-)” rating to a “hold (c)” rating in a report on Friday, July 17th. Wall Street Zen upgraded shares of Chemed from a “hold” rating to a “strong-buy” rating in a research report on Saturday, August 1st. Bank of America reaffirmed a “neutral” rating on shares of Chemed in a research note on Wednesday, July 29th. Oppenheimer boosted their target price on shares of Chemed from $500.00 to $590.00 and gave the company an “outperform” rating in a report on Friday, July 31st. Finally, Royal Bank Of Canada increased their price target on shares of Chemed from $436.00 to $548.00 and gave the company a “sector perform” rating in a research note on Thursday, July 30th. One investment analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $530.75.

Chemed Stock Down 0.7%

Chemed stock opened at $520.82 on Friday. The company has a market capitalization of $6.81 billion, a PE ratio of 26.16, a price-to-earnings-growth ratio of 1.99 and a beta of 0.51. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.89 and a current ratio of 0.91. Chemed Corporation has a fifty-two week low of $365.20 and a fifty-two week high of $557.00. The firm has a 50 day moving average price of $516.70 and a 200 day moving average price of $451.82.

Chemed (NYSE:CHE) last released its quarterly earnings results on Tuesday, July 28th. The company reported $6.06 EPS for the quarter, topping analysts’ consensus estimates of $5.60 by $0.46. Chemed had a return on equity of 31.77% and a net margin of 10.60%.The company had revenue of $673.25 million for the quarter, compared to analysts’ expectations of $665.04 million. During the same period in the prior year, the firm earned $4.27 earnings per share. The firm’s revenue was up 8.8% compared to the same quarter last year. Chemed has set its FY 2026 guidance at 25.000-25.750 EPS. Research analysts expect that Chemed Corporation will post 23.18 earnings per share for the current year.

Chemed Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, September 3rd. Investors of record on Monday, August 17th were issued a dividend of $0.70 per share. This is a positive change from Chemed’s previous quarterly dividend of $0.60. The ex-dividend date was Monday, August 17th. This represents a $2.80 dividend on an annualized basis and a yield of 0.5%. Chemed’s dividend payout ratio (DPR) is 14.06%.

Insider Transactions at Chemed

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Monday, August 3rd. The shares were sold at an average price of $539.51, for a total transaction of $1,079,020.00. Following the sale, the chief executive officer owned 70,418 shares of the company’s stock, valued at approximately $37,991,215.18. This represents a 2.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, EVP Spencer S. Lee sold 1,000 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $541.04, for a total transaction of $541,040.00. Following the completion of the transaction, the executive vice president directly owned 13,912 shares of the company’s stock, valued at approximately $7,526,948.48. The trade was a 6.71% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 6,537 shares of company stock valued at $3,406,014. Insiders own 3.33% of the company’s stock.

Chemed Company Profile

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.